| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,626 |
3,107 |
$263K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
3,434 |
3,044 |
$194K |
| 36415 |
Collection of venous blood by venipuncture |
8,656 |
6,107 |
$178K |
| 80053 |
Comprehensive metabolic panel |
5,722 |
4,491 |
$178K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
5,930 |
4,789 |
$144K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
743 |
677 |
$138K |
| 81001 |
|
3,340 |
2,907 |
$87K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
2,041 |
1,773 |
$73K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
1,862 |
1,504 |
$64K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,881 |
1,549 |
$64K |
| J7030 |
Infusion, normal saline solution , 1000 cc |
1,549 |
1,004 |
$63K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,471 |
1,938 |
$63K |
| J2704 |
Injection, propofol, 10 mg |
1,267 |
678 |
$57K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
1,461 |
1,105 |
$56K |
| 70450 |
Computed tomography, head or brain; without contrast material |
897 |
825 |
$54K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
2,008 |
1,572 |
$53K |
| 85027 |
|
2,034 |
1,382 |
$53K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
531 |
499 |
$52K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
1,434 |
909 |
$51K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
420 |
355 |
$49K |
| 84703 |
|
1,111 |
963 |
$49K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
714 |
651 |
$48K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
873 |
786 |
$46K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
910 |
779 |
$46K |
| 84484 |
|
2,220 |
1,421 |
$45K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,497 |
1,388 |
$44K |
| 83690 |
|
1,582 |
1,352 |
$41K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
576 |
508 |
$39K |
| 71046 |
Radiologic examination, chest; 2 views |
1,638 |
1,490 |
$39K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
988 |
542 |
$36K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,113 |
1,417 |
$35K |
| 96376 |
|
788 |
499 |
$34K |
| 82150 |
|
1,181 |
1,039 |
$33K |
| 87040 |
|
1,012 |
920 |
$32K |
| 82553 |
|
1,309 |
942 |
$29K |
| 83605 |
|
942 |
795 |
$28K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
255 |
203 |
$27K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,035 |
910 |
$26K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
711 |
653 |
$26K |
| J7120 |
Ringers lactate infusion, up to 1000 cc |
562 |
441 |
$25K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
340 |
317 |
$25K |
| 82550 |
|
1,387 |
1,002 |
$24K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
657 |
336 |
$23K |
| 71045 |
Radiologic examination, chest; single view |
1,370 |
1,086 |
$22K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
512 |
477 |
$20K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
434 |
354 |
$20K |
| 85610 |
|
1,222 |
934 |
$18K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
937 |
503 |
$17K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
726 |
552 |
$17K |
| 85730 |
|
905 |
804 |
$17K |
| 86140 |
|
553 |
496 |
$16K |
| 85378 |
|
469 |
446 |
$16K |
| J3490 |
Unclassified drugs |
465 |
354 |
$15K |
| 80061 |
Lipid panel |
787 |
736 |
$15K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
749 |
564 |
$15K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
191 |
152 |
$14K |
| 73562 |
|
432 |
393 |
$14K |
| 85007 |
|
808 |
670 |
$14K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
212 |
200 |
$13K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
551 |
511 |
$13K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
547 |
419 |
$12K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
176 |
158 |
$12K |
| 76770 |
|
216 |
206 |
$12K |
| 83735 |
|
535 |
463 |
$12K |
| 93017 |
|
79 |
74 |
$12K |
| 72110 |
|
274 |
264 |
$11K |
| 84439 |
|
448 |
422 |
$10K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
271 |
261 |
$9K |
| 93971 |
|
176 |
163 |
$9K |
| 83880 |
|
364 |
326 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
352 |
325 |
$9K |
| 73610 |
|
252 |
232 |
$8K |
| 73130 |
|
223 |
199 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
481 |
456 |
$8K |
| 87186 |
|
495 |
455 |
$8K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
311 |
280 |
$7K |
| 76830 |
Ultrasound, transvaginal |
133 |
126 |
$7K |
| 73030 |
|
247 |
232 |
$7K |
| 88342 |
|
88 |
69 |
$6K |
| 87081 |
|
292 |
273 |
$6K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
257 |
226 |
$6K |
| J1815 |
Injection, insulin, per 5 units |
369 |
181 |
$6K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
194 |
147 |
$5K |
| 76536 |
|
93 |
90 |
$5K |
| 73630 |
|
239 |
221 |
$5K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
109 |
102 |
$5K |
| 73110 |
|
89 |
86 |
$5K |
| 72050 |
|
115 |
109 |
$5K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
38 |
38 |
$5K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
38 |
38 |
$5K |
| 74019 |
|
170 |
153 |
$4K |
| 90715 |
|
90 |
89 |
$4K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
73 |
72 |
$4K |
| 76642 |
|
82 |
70 |
$4K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
292 |
222 |
$4K |
| 74018 |
|
230 |
198 |
$4K |
| 78227 |
|
14 |
14 |
$4K |
| 82607 |
|
147 |
137 |
$4K |
| 71250 |
|
57 |
54 |
$4K |
| 85651 |
|
261 |
242 |
$4K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
150 |
115 |
$4K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
13 |
13 |
$4K |
| 93880 |
|
16 |
13 |
$4K |
| 72100 |
|
135 |
129 |
$3K |
| 73502 |
|
126 |
114 |
$3K |
| 86901 |
|
98 |
87 |
$3K |
| 86900 |
|
98 |
87 |
$3K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
86 |
77 |
$3K |
| 83540 |
|
172 |
157 |
$3K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
110 |
95 |
$3K |
| 82570 |
|
191 |
183 |
$3K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
108 |
96 |
$3K |
| 72072 |
|
76 |
73 |
$3K |
| 86850 |
|
93 |
81 |
$3K |
| 82728 |
|
117 |
106 |
$3K |
| 94761 |
|
190 |
97 |
$2K |
| 80074 |
|
78 |
76 |
$2K |
| 72131 |
|
33 |
31 |
$2K |
| 86756 |
|
88 |
76 |
$2K |
| J2060 |
Injection, lorazepam, 2 mg |
79 |
59 |
$2K |
| 74022 |
|
67 |
58 |
$2K |
| 87070 |
|
116 |
107 |
$2K |
| 82043 |
|
90 |
85 |
$2K |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
56 |
31 |
$2K |
| 77065 |
Tomosynthesis, mammo |
40 |
40 |
$2K |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
66 |
54 |
$1K |
| 88304 |
|
40 |
29 |
$1K |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
67 |
55 |
$1K |
| A9537 |
Technetium tc-99m mebrofenin, diagnostic, per study dose, up to 15 millicuries |
15 |
14 |
$1K |
| J2780 |
Injection, ranitidine hydrochloride, 25 mg |
75 |
55 |
$1K |
| J2300 |
Injection, nalbuphine hydrochloride, per 10 mg |
32 |
12 |
$1K |
| 73090 |
|
18 |
18 |
$1K |
| 51702 |
|
106 |
102 |
$1K |
| 84436 |
|
62 |
56 |
$1K |
| 84479 |
|
46 |
40 |
$927.53 |
| 84702 |
|
38 |
30 |
$848.77 |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
13 |
12 |
$824.96 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
79 |
16 |
$735.08 |
| 93225 |
|
32 |
31 |
$664.73 |
| 80076 |
|
16 |
14 |
$624.09 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
50 |
50 |
$606.84 |
| 82784 |
|
35 |
33 |
$595.41 |
| 97035 |
|
28 |
12 |
$461.48 |
| 86592 |
|
28 |
26 |
$392.30 |
| 83516 |
|
17 |
16 |
$391.81 |
| 97014 |
|
43 |
12 |
$391.64 |
| 73590 |
|
12 |
12 |
$385.36 |
| 82140 |
|
12 |
12 |
$368.62 |
| J2360 |
Injection, orphenadrine citrate, up to 60 mg |
16 |
14 |
$292.45 |
| 73080 |
|
16 |
12 |
$171.00 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
44 |
30 |
$148.67 |
| 87210 |
|
17 |
13 |
$141.14 |
| 87220 |
|
17 |
13 |
$139.46 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
17 |
17 |
$135.68 |
| J1956 |
Injection, levofloxacin, 250 mg |
19 |
13 |
$100.17 |
| G0378 |
Hospital observation service, per hour |
13 |
13 |
$95.12 |
| 51701 |
|
13 |
12 |
$90.93 |
| 86255 |
|
16 |
14 |
$64.11 |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
16 |
13 |
$20.90 |
| 94664 |
|
12 |
12 |
$14.80 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
127 |
116 |
$0.00 |
| 1036F |
|
128 |
116 |
$0.00 |
| 1123F |
|
13 |
13 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
28 |
27 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
184 |
170 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
106 |
96 |
$0.00 |
| 4004F |
|
29 |
28 |
$0.00 |